Choose Your Language
Home  /  Why get a NIPT by GenePlanet?

Why get a NIPT by GenePlanet?

Available from week 10 of pregnancy, the NIPT by GenePlanet gives you an early option to know more about the genetic health of your baby.

Compared to traditional screening tests, the NIPT by GenePlanet offers higher accuracy and lower false positive rates. This means that less women will undergo invasive diagnostic procedures such as amniocentesis or chorionic villus sampling which carry a 1-2% risk of miscarriage.

NIPT by GenePlanet is non-invasive and therefore poses no risk to the mother or baby.

Is the NIPT by GenePlanet Test Right for Me?


The NIPT by GenePlanet is available to any pregnant woman from the 10th week of pregnancy but is particularly suitable for pregnant women who exhibit certain indications which are highlighted below.

Prior to undertaking any non-invasive prenatal testing, you should consult a qualified healthcare professional regarding any risks, diagnoses, treatment and/or any other potentially relevant healthcare issues.

The NIPT by GenePlanet test is suitable if you exhibit
any of the following indications:

Maternal age 35 years or
older at delivery
Contraindications for invasive prenatal testing, such as placenta prevaria, risk of miscarriage or HBV infection
Fetal ultrasonographic findings indicating an increased risk of aneuploidy
History of a prior pregnancy with a trisomy
Require reassurance following previous screening result
Parental balanced robertsonian translocation with increased risk of fetal trisomy 13 or trisomy 21
Received IVF Treatment or have previosuly suffered from habitual abortion

NSGC (National Society of Genetic Counselors)
The NSGC supports NIPT as an option for patients whose pregnancies are considered to be at an increased risk of certain chromosome abnormalities. Patients whose NIPT results are abnormal, or who have other factors suggestive of a chromosome abnormality, should receive genetic counselling and be given the option of standard confirmatory diagnostic testing.